Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer
Clinical trial NCT05573373 · UNKNOWN
Trial details
- NCT number
- NCT05573373
- Sponsor
- Affiliated Hospital of Jiangnan University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2024-11-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.